Publication:
B-type natriuretic peptide levels in patients with COPD and normal right ventricular function

dc.contributor.authorİNANIR, SABAHAT
dc.contributor.authorTOKAY TARHAN, SENA
dc.contributor.authorÖNEŞ, TUNÇ
dc.contributor.authorsGemici, Goekwen; Erdim, Refik; Celiker, Aydin; Tokay, Sena; Ones, Tunc; Inanir, Sabahat; Oktay, Ahmet
dc.date.accessioned2022-03-12T17:35:27Z
dc.date.accessioned2026-01-11T17:13:25Z
dc.date.available2022-03-12T17:35:27Z
dc.date.issued2008
dc.description.abstractIntroduction: Evidence suggests that elevated plasma levels of B-type natriuretic peptide (BNP) are found in patients with chronic obstructive pulmonary disease (COPD) and right ventricular dysfunction. We examined the effects of exercise on plasma BNP levels in patients with COPD who have normal right ventricular function. Methods: Seventeen patients with a diagnosis of COPD and normal right ventricular function demonstrated by radionuclide ventriculography, and 17 age- and sex-matched healthy subjects underwent a treadmill exercise test. Plasma BNP levels were measured sequentially before, immediately after, and 1 hour after the exercise test. Results: The mean plasma BNP +/- standard deviation levels of the COPD and control groups before exercise were 21.3 +/- 16 pg/ml and 13.4 +/- 11 pg/ml, respectively (P>0.05). Mean plasma BNP level measured immediately after exercise was 37.9 +/- 31 pg/ml in the COPD group, reflecting a statistically significant increase when compared with the initial value (P<0.05). The control group did not show any significant change in plasma BNP levels after the exercise test. Conclusion: Exercise induces an increase in plasma BNP levels in patients with COPD who do not have right ventricular dysfunction at rest. Measurement of exercise-induced BNP levels may be a useful alternative to pulmonary artery catheterisation in identifying the patients who are likely to benefit from long-term oxygen therapy.
dc.identifier.doi10.1007/s12325-008-0067-1
dc.identifier.eissn1865-8652
dc.identifier.issn0741-238X
dc.identifier.pubmed18563310
dc.identifier.urihttps://hdl.handle.net/11424/229163
dc.identifier.wosWOS:000258652800004
dc.language.isoeng
dc.publisherSPRINGER
dc.relation.ispartofADVANCES IN THERAPY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectbrain natriuretic peptide
dc.subjectchronic obstructive pulmonary disease
dc.subjectright ventricle
dc.subjectOBSTRUCTIVE PULMONARY-DISEASE
dc.subjectTERM OXYGEN-THERAPY
dc.subjectBRAIN
dc.subjectHEMODYNAMICS
dc.subjectHYPERTENSION
dc.subjectDYSFUNCTION
dc.subjectBENEFITS
dc.subjectATRIAL
dc.titleB-type natriuretic peptide levels in patients with COPD and normal right ventricular function
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage680
oaire.citation.issue7
oaire.citation.startPage674
oaire.citation.titleADVANCES IN THERAPY
oaire.citation.volume25

Files